Stock Strategist

We assess the Morningstar rating for stocks through three lenses.

We think this no-moat company’s shares are undervalued.

Higher prices from elevated snowfall should more than offset near-term operational challenges.

The wide-moat company leads the market in medical technology.

We believe the current share price already reflects much of what could go wrong.

The market's fascination with heated tobacco has left this company unloved.

The wide-moat company is working to boost sales as well as profitability.

Innovation enables increasing dollar content per vehicle and bolsters margins.

We think much of the possible downside is accounted for in the current price.

The undervalued carrier is set for more aggressive growth with the launch of 4G services and 5G on the horizon.

We think the market is overreacting to the news of lower first-quarter production.

Improved profitability should follow the apparel maker's return to revenue growth.

Its products are the industry standard for creative professionals.

Robust travel demand supports pricing growth for the cruise operator, driving profit gains.

Its plan to increase capital spending sets it apart from integrated peers.

We think fears regarding the company's near-term profitability are exaggerated.

Good year-end results are evidence of AB InBev’s strong competitive positioning.

Its place at the intersection of purchasing and analytics creates a narrow moat.

Expansion abroad, aided by recent M&A, bodes well for the top and bottom lines.

A growing portfolio of rare-disease drugs digs a moat for the company.

Few can match the company's pervasive presence in hospitals.

REX plays an important part in the U.S. natural gas market.

It’s building its brand equity globally and across segments.

It is reinstating the cash dividend, with plans to increase it.

This wide-moat company is the world’s largest pure-play software-as-a-service vendor.

Positive flows, market gains, and acquisitions should drive assets under management higher.

We think the snack maker is well suited to cater to consumers' continued desire to indulge.

It's one of the lowest-cost oil producers in our coverage universe.

The waste-to-energy operator should benefit from global sustainability initiatives.

The new CEO's background inspires confidence that he can fix issues.

The stock price implies the worst-case scenario for this wide-moat company.

Its programming reaches audiences across cultures and languages.

With the help of tax reform, the company’s earnings should more than double in five years.

We believe customer switching costs are decreasing.

We believe Pershing Square's argument for doing so is flawed and nearsighted.

There is opportunity for investors when the market revalues the company as a fully regulated narrow-moat utility.

And the company continues to reward investors with annual dividend growth.

Its network and efficient scale advantages are intact, despite exaggerated disintermediation fears.

We think many of its drugs are relatively more resistant to patent cliffs or sales pressure from generics.

The carrier now has the ability to offer all services on its own network.

The market underestimates our top pick for U.S. infrastructure.

But while we foresee some sales improvement, increasing already-high margins is not likely.

It's working at getting the scale that only automakers its size can reach, and it's succeeding.

We see two tangible growth drivers: high-speed optics for datacom and 3-D sensing lasers in smartphones.

Its modern software platform is creating a dominant market position.

The company’s transformation and an improving summer 2018 slate should lead to a bounceback.

We view the deal favorably for both companies’ shareholders.

Our fair value estimate is unchanged after a rough third quarter.

We think the wide-moat company is still a bit undervalued.

This moaty business should drive Alphabet’s earnings higher.